CA153 and CEA yielded an AUC of 0.799 (specificity: 76.0%; sensitivity: 68.3%) and 0.784 (specificity: 83.8%, sensitivity: 72.5%) for discriminating BC cases from controls (Figure 2B,C). Here, CEACAM5 is linked to breast cancer.